Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Segment Highlights
ABT logo

Abbott Labs' Medical Devices Surge 12.5% Amid Global Growth

ABT10-QFiling Date: 10/29/2025
Abbott Laboratories
Description

What this story covers

Abbott Laboratories reported Q3 2025 net sales of $11.3B, up 5.5% FX-neutral, driven by 12.5% medical devices growth offsetting diagnostics declines from fading COVID tests. Year-to-date sales hit $32.8B, with strong nutrition and pharma segments, improved margins, robust liquidity, and ongoing innovations in cardiovascular and diabetes care.

Story snapshot

CompanyAbbott Laboratories
TickerABT
VariantStandard detailed
Duration13:19
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001628280-25-047131

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in